{"id":"W2329699817","doi":"10.1097/mpg.0000000000001149","title":"Time for Personalized Biologic Therapy","year":2016,"lang":"en","type":"letter","venue":"Journal of Pediatric Gastroenterology and Nutrition","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Infliximab; Ulcerative colitis; Inflammatory bowel disease; Dosing; Disease; Crohn's disease; Internal medicine; Vedolizumab; Adalimumab; Clinical trial; Drug; Immunology; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00326817,0.0009771228,0.0009791356,0.001063132,0.001284935,0.006779884,0.001405558,0.006400297,0.3480439],"category_scores_gemma":[0.01286096,0.0004868279,0.001250595,0.0007643263,0.001173093,0.006875112,0.00569951,0.01139134,0.2134349],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001791627,"about_ca_system_score_gemma":0.002537523,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009326204,"about_ca_topic_score_gemma":0.002261336,"domain_scores_codex":[0.9968727,0.000963999,0.0002288727,0.0004673487,0.001161874,0.0003052143],"domain_scores_gemma":[0.9933989,0.00154011,0.0003991404,0.0008313616,0.001554605,0.002275923],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002347722,0.00002602962,0.00009250489,0.0001030522,0.00001409148,0.000052055,0.00003711769,0.00004591652,0.0001205448,0.006384722,0.9119,0.08120059],"study_design_scores_gemma":[0.0000135155,0.00001160637,0.0001080549,0.0001187233,0.000004090593,0.0000695973,0.00002289523,0.00002683583,0.00003482841,0.003276773,0.9963082,0.00000494806],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0008587895,0.0359267,0.01393871,0.4865106,0.1135984,0.0002673802,0.00335587,0.00435002,0.3411935],"genre_scores_gemma":[0.01378573,0.03564371,0.01623353,0.3821095,0.06660001,0.0004133902,0.004351472,0.002367243,0.4784954],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.3480439,"threshold_uncertainty_score":0.9299363,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02254318816610979,"score_gpt":0.2691309600622989,"score_spread":0.2465877718961891,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}